Studies on apolipoprotein B and E genes in familial hyperlipidemias
Studies on apolipoprotein B and E genes in familial hyperlipidemias
批准号:
59480198
负责人:
MABUCHI Hiroshi
金额:
$2.56万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (B)
财政年份:
1984
资助国家:
日本
项目状态:
已结题
起止时间:
1984 至 1986
中文摘要
为了构建成人肝脏载脂蛋白E cDNA文库,合成了载脂蛋白E氨基酸218 ~ 222对应的寡核苷酸。利用8个载脂蛋白E cDNA克隆之一(pAPOE7)作为载脂蛋白E DNA探针,研究了载脂蛋白E缺乏症患者的基因组DNA。用Hind III或EcoRI消化5微克载子E缺乏症患者的基因组DNA,分别产生约1.9和12 Kb的杂交带。正常对照和先证者DNA杂交带的大小相同。采用人LDL受体(LDlR)全长cDNA (pLDLR-3)和部分cDNA (pLDLR-2HHI)作为LDlR DNA探针,研究家族性高胆固醇血症(FH)患者和正常人的基因组DNA。PvuII对LDLR的限制性片段长度多态性(RFLP)分析显示等位基因A (16.5kb和3.5kb)和等位基因B (14.0kb、3.5kb和2.5kb)。测定了28例FH患者和13例正常人的RFLP频率。FH和正常人的A、B等位基因频率分别为0.08和0.13,0.72和0.08。2例FH患者(K.Y.和S.O.)表现出LDLR基因片段异常。用各种限制性内切酶消化后,我们认为这两名患者有一个共同的突变型LDLR等位基因,缺失6kb,缺失区域位于15号外显子5'端附近,一直到15号内含子的Hind III位点。在K.Y.家族11名成员中,FH表型和LDLR异常片段完全共分离。S.O家族中,S.O及其两个女儿(M.T.和C.M.)均有FH, LDLR基因片段出现异常。M.T.的血清胆固醇水平胎儿的血压是78毫克/分升。在Southern blotting分析中,婴儿发现了一个异常的10.5kb片段。另一方面,C.M.婴儿胆固醇正常(51 mg/dl),无LDLR基因异常,诊断为正常受试者。我们将携带这种新突变基因的患者命名为“FH-Tonami”。少
英文摘要
To probe a human adult liver cDNA library for apo-E cDNA clones, an oligonucleotide corresponding to apo E amino acids 218 to 222 was synthesized. One of 8 apoE cDNA clone (pAPOE7) was used as an apo E DNA probe for study of genomic DNA from a patient with apo E deficiency. Five micrograms of genomic DNA of apo E deficiency patient digested with Hind III or EcoRI, produced hybridization bands of approximately 1.9 and 12 Kb, respectively. The sizes of the hybridization bands were the same for normal controls and the proband's DNA.Full length cDNA (pLDLR-3) and partial cDNA (pLDLR-2HHI) for human LDL receptor (LDlR) were used as LDLR DNA probes for studying genomic DNA from patients with familial hypercholesterolemia (FH) and normal subjects. Restriction fragment length polymorphism (RFLP) study of LDLR by PvuII showed allele A (16.5kb and 3.5kb) and allele B (14.0kb, 3.5kb and 2.5kb). The frequencies of the RFLP were determined in 28 FH patients and 13 normal subjects. The frequencies o … More f allele A and B in FH and normal subjects were 0.08 and 0.13, and 0.72 and 0.08, respectively.Two patients (K.Y. and S.O.) with FH showed an abnormal fragment pattern of LDLR gene. After digestions with various restriction enzymes, we considered that these two patients had a common mutant LDLR allele that had a 6kb deletion, and the deletion encompassed an area near the 5' end of exon 15 up to the Hind III site in intron 15. The FH phenotype and the abnormal fragment of LDLR completely cosegregated in all the 11 members of the family of K.Y. In the family of S.O, S.O and her two daughters (M.T. and C.M.) with FH showed an abnormal gragment of LDLR gene. The serum cholesterol levels of M.T.'s baby was 78 mg/dl. On Southern blotting analysis, the baby revealed an abnormal 10.5kb fragment. On the other hand, C.M.'s baby was normocholesterolemic (51 mg/dl) and showed no abnormal LDLR gene and was diagnosed as normal subject. We designated the patients with this new mutant gene as "FH-Tonami". Less
期刊论文(32)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
梶波康二,馬渕宏: Medical Way. 3. 83-90 (1986)
Koji Kajinami、Hiroshi Mabuchi:医学之路。3. 83-90 (1986)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kouji Kajinami et al.: "Studies on bovine LDL receptor cDNA." J.Japan Atherosclerosis Society. 13. 1353-1356 (1986)
Kouji Kajinami 等人:“牛 LDL 受体 cDNA 的研究”。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kouji Kajinami, et al.: "Diagnosis of familial hypercholesterolemia by LDL receptor gene analysis." Medical Way. 3. 83-90 (1986)
Kouji Kajinami 等人:“通过 LDL 受体基因分析诊断家族性高胆固醇血症。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
梶波康二,武田三昭,伊藤英章,酒井泰征,道下一朗,嘉門信雄,坂井健志,若杉隆伸,馬渕宏,竹田亮祐: 動脈硬化. 13. 1353-1356 (1986)
Koji Kajinami、Mitsuaki Takeda、Hideaki Ito、Yasuyuki Sakai、Ichiro Michishita、Nobuo Kamon、Kenji Sakai、Takanobu Wakasugi、Hiroshi Mabuchi、Ryosuke Takeda:动脉硬化。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
馬渕宏,伊藤英章,武田三昭,梶波康二,若杉隆伸,竹田亮祐: Therapeutic Research. 5. 306-311 (1986)
Hiroshi Mabuchi、Hideaki Ito、Mitsuaki Takeda、Koji Kajinami、Takanobu Wakasugi、Ryosuke Takeda:治疗研究。5. 306-311 (1986)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 14 条
DEVELOPMENT OF LIGHT WEIGHT Ll_2-Al_3Ti ALLOYS AND FORMATION OF GRADED OXIDATION-RESISTANT LAYER FOR TiAl ALLOYS.
-
批准号:12450285
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$6.14万
-
财政年份:2000
-
负责人:MABUCHI Hiroshi
-
依托单位:
Study on Phase Stability of Light Weight-High Temperature LlィイD22ィエD2-AlィイD23ィエD2Ti Based Alloys.
-
批准号:10650695
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.18万
-
财政年份:1998
-
负责人:MABUCHI Hiroshi
-
依托单位:
MOLECULAR GENETICS OF CHOLESTEROL METABOLIC PATHWAY AND TREATMENT OF ATHEROSCLEEROSIS
-
批准号:09307010
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$17.6万
-
财政年份:1997
-
负责人:MABUCHI Hiroshi
-
依托单位:
GENE DIAGNOSIS AND GENE THERAPY OF CHOLESTEROL TRANSPORT AND CHOLESTEROL REVERSE TRANSPORT DISORDERS
-
批准号:07457123
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$3.97万
-
财政年份:1995
-
负责人:MABUCHI Hiroshi
-
依托单位:
Development of Light Weight-High Temperature Structural L1_2 Compounds in Al_3Ti-Base Alloys.
-
批准号:07650822
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.41万
-
财政年份:1995
-
负责人:MABUCHI Hiroshi
-
依托单位:
MOLECULAR GENETICS OF CHOLESTEROL TRANSPORT AND CHOLESTEROL REVERSE TRANSPORT DISORDERS
-
批准号:04454235
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$3.9万
-
财政年份:1992
-
负责人:MABUCHI Hiroshi
-
依托单位:
Molecular Genetics of Familial Hyperlipidemias
-
批准号:63480187
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$3.9万
-
财政年份:1988
-
负责人:MABUCHI Hiroshi
-
依托单位:
海外基金